Capsulution - LBL-Technology® - Unique Multifunctional Nano- and Micron-Sized Capsules

Capsulution is committed to develop outstanding encapsulation systems for the life science industry. Using its expertise in LBL-Technology®, the company provides its industrial partners with key innovations tailored to their increasing needs for differentiating products on the pharmaceutical market as well as for medical devices and cosmetic applications.

LBL-TECHNOLOGY® - INVISIBLE NANO- AND MICRON-SIZED CAPSULES

The LBL-Technology® (derived from the term "layer-by-layer") is a high-tech tool for making unique multifunctional nano- and micron-sized capsules which are invisible to the human eye.

For instance, the head of a pin, 1.5mm across, could contain some three thousand million capsules. Functionally designed and custom-made, these capsules suit a variety of pharmaceutical and non-pharmaceutical purposes which not only allow the development of a variety of advanced drug-delivery products, but can also be applied to other types of products, such as foodstuffs and food ingredients, nutraceuticals, diagnostics, biosensors, enzyme catalysts, paper, and paints. In fact, there may be no other encapsulation technology available which provides such high-end capsules.

NON-INVASIVE BLOOD SUGAR MEASUREMENT AND DRUG SUBSTANCE PROTECTION

The company provides its world wide patented LBL-Technologie® encompassing of more than 16 patent families to design unique nano- and micron sized-capsules thus enabling the development of products ranging from the non-invasive blood sugar measurement to the stabilization and protection of drug substances. To achieve high quality products in the various application sectors, the capsules can be produced in any size (from 500 nanometres up to 50 microns) and be fitted with almost any biochemical, electrical, optical and magnetic features.

The highlights of the LBL-Technology® are as follows:

• Extreme control of capsule size and shape
• Exact manipulation of wall thickness and structure
• Large number of biological or synthetic wall materials
• Precise and sophisticated functional surface design
• Manufacture of hollow capsules
• High reproducibility

HIGH REPUTATION AMONG CLIENTS AND PARTNERS

In its first years, Capsulution successfully presented its innovative technology, winning a high level of interest among major business clients such as Bayer, Ciba Vision, Gelita, SCA Hygiene Products, Cognis, RP Scherer, OctoPlus, along with many undisclosed clients. As a result, the company has already achieved total revenues exceeding €1.2 million and is expecting royalties of more than €10 million (net present value) from ongoing product developments. Capsulution's success has, in addition, drawn support from various public-funding programmes. The Berlin based company currently employs 16 highly qualified professionals.